Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Germline variation in O6-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer.

Belhadj S, Moutinho C, Mur P, Setien F, Llinàs-Arias P, Pérez-Salvia M, Pons T, Pineda M, Brunet J, Navarro M, Capellá G, Esteller M, Valle L.

Cancer Lett. 2019 Jan 21;447:86-92. doi: 10.1016/j.canlet.2019.01.019. [Epub ahead of print]

2.

In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma.

Pérez-Salvia M, Aldaba E, Vara Y, Fabre M, Ferrer C, Masdeu C, Zubia A, Sebastian ES, Otaegui D, Llinàs-Arias P, Rosselló-Tortella M, Berdasco M, Moutinho C, Setien F, Villanueva A, González-Barca E, Muncunill J, Navarro JT, Piris MA, Cossio FP, Esteller M.

Haematologica. 2018 Nov;103(11):e537-e540. doi: 10.3324/haematol.2018.189241. Epub 2018 Jun 7. No abstract available.

3.

Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.

Llinàs-Arias P, Esteller M.

Open Biol. 2017 Sep;7(9). pii: 170152. doi: 10.1098/rsob.170152. Review.

4.

Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer.

Pérez-Salvia M, Simó-Riudalbas L, Llinàs-Arias P, Roa L, Setien F, Soler M, de Moura MC, Bradner JE, Gonzalez-Suarez E, Moutinho C, Esteller M.

Oncotarget. 2017 May 29;8(31):51621-51629. doi: 10.18632/oncotarget.18255. eCollection 2017 Aug 1.

Supplemental Content

Loading ...
Support Center